<DOC>
	<DOCNO>NCT00005400</DOCNO>
	<brief_summary>To examine angiotensinogen genetic variant adverse pregnancy outcome .</brief_summary>
	<brief_title>Angiotensinogen Variants Adverse Pregnancy Outcomes</brief_title>
	<detailed_description>BACKGROUND : Early gestation maternal blood volume normally expand unknown mechanism ; failure normal adaptation pregnancy associate common adverse pregnancy outcome include preeclampsia , intrauterine growth retardation , premature labor . The renin-angiotensin system critical role control maternal fluid volume probably pathophysiology serious complication pregnancy . Kenneth Ward group recently discover DNA variant cause amino acid substitution angiotensinogen ( renin substrate ) , one ( T235 ) strongly associate preeclampsia . They hypothesize functionally different angiotensinogen protein may underlie pathophysiology preeclampsia relate disorder ( intrauterine growth retardation premature labor ) allow normal volume expansion occur . The four interrelate approach study lead well understanding role angiotensinogen pregnancy pathophysiology preeclampsia . Unlike previous find preeclamptic patient , genetic alteration angiotensinogen describe intrinsic defect , although may modify factor , 'secondary ' pathophysiologic variable . This molecular hypothesis demand reinterpretation many prior finding preeclampsia , fetal growth retardation , premature labor base angiotensinogen genotype . The DNA plasma collect study invaluable resource future molecular investigation abnormal pregnancy . DESIGN NARRATIVE : Four different strategy use . First , prospective , epidemiologic survey 24,000 pregnancy conduct determine role T235 variant common disorder pregnancy . From population , nulligravida volunteer , 150 homozygous T235 variant 150 homozygous alternative M235 allele , select longitudinal study maternal-fetal physiology biochemistry order determine T235 variant exert adverse effect . Taking advantage large average family size Utah , female relative woman preeclampsia also study order define genetics important angiotensinogen variant . Finally , DNA preeclamptic patient examine additional mutation angiotensinogen gene may offer unique pathophysiologic insight . The study renew 1999 another four year investigate hypothesis disease-associated angiotensinogen allele promote abnormal spiral artery remodel inhibit maternal plasma volume expansion .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Eclampsia</mesh_term>
	<criteria>No eligibility criterion</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>